Clinical Trial Update: P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

View source ↗

Summary

A clinical trial is recruiting to evaluate a potassium-competitive acid blocker-based bismuth quadruple therapy for eradicating Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• P-CAB-based Bismuth Quadruple Therapy

Snippet

Sponsor: Yueyue Li | Conditions: Helicobacter Pylori Infection | Status: RECRUITING